This evidence-based review evaluates the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis.
The Quality Standards Subcommittee of the American Academy of Neurology (AAN) is charged with developing practice parameters for neurologists for diagnostic procedures, treatment modalities, and clinical disorders. The selection of topics for which practice parameters are used is based on prevalence, frequency of use, economic impact, membership involvement, controversy, urgency, external constraints, and resources required. This article addresses the usefulness of evoked potentials (EPs) in identifying clinically silent lesions in patients with suspected MS.
Gronseth et al. (Tue,) conducted a review in Suspected multiple sclerosis. Evoked potentials (EPs) was evaluated on Identification of clinically silent lesions. This evidence-based review evaluates the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis.